emea Archives - Kotter International Inc

A heatmap of Europe showing varied AI adoption rates across different countries, used to illustrate the leadership challenge in regional AI transformation.

AI + Digital Transformation Blog EMEA Growth Workplace

Europe’s AI Map Reveals a Leadership Challenge

Is your AI strategy locally grounded? Discover why a one-size-fits-all rollout fails in Europe’s diverse…

Pinelopi MargetiMay 7, 2026

European steel or cement plant representing CBAM-affected industries

AI + Digital Transformation Blog EMEA Energy + Natural Resources Kotter Insights Leading Through Crisis Manufacturing Operational Efficiency

CBAM Compliance Alone Is Not Enough

Compliance alone will not prepare companies for CBAM’s definitive phase. Leaders must mobilize cross-functional teams,…

Nick PetschekFebruary 23, 2026

Counterfeit drugs are rising as viral demand outpaces regulation. Learn how pharma leaders can protect trust, safety, and innovation.

Blog EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

Question of Trust: How Pharma Leaders Can Respond to Counterfeit Drug Risk

The news that Hein Schumacher is set to take over from Barry Callebaut CEO Peter…

Nick PetschekFebruary 2, 2026

Blog Culture Change EMEA Kotter In The News Kotter Insights Leading Through Crisis Retail

Barry Callebaut leadership reset – why and what come next?

The news that Hein Schumacher is set to take over from Barry Callebaut CEO Peter…

Nick PetschekJanuary 27, 2026

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in ways that were unimaginable a decade ago. Yet despite these advances, sustaining innovation has become harder than ever. Development costs are climbing, competition for talent is intensifying and many of the most exciting early-stage innovations are now coming from biotech and academic partners. At the same time, a new generation of scientists is entering the field with different expectations. They look for trust, adaptability and purpose, not rigid hierarchies and incremental progress.

Blog Culture Change EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

The Future of Pharma R+D Leadership

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in…

Nick PetschekJanuary 27, 2026

"When innovation outpaces regulation pharma leaders must cross organisational boundaries" - Nick Petschek, EMEA MD at Kotter.

AI + Digital Transformation Blog Culture Change EMEA Healthcare Innovation Kotter In The News Kotter Insights Pharma + Biotech Technology

When Innovation Outpaces Regulation

Addressing the threat of unlicensed drugs requires coordinated action across every industry tier, from pharma…

Nick PetschekJanuary 15, 2026